Bridgeway Capital Management’s Avita Medical RCEL Stock Holding History

Bridgeway Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,404	Closed	-$112K	–	1299
2026 Q1	$112K	Sell	30,404 -87,600	-74%	-$368K	﹤0.01%	1115
2025 Q4	$407K	Hold	118,004	–	–	0.01%	864
2025 Q3	$603K	Buy	118,004 +80,404	+214%	+$420K	0.01%	767
2025 Q2	$199K	Buy	+37,600	New	+$274K	﹤0.01%	962
2024 Q1	–	Sell	-28,518	Closed	-$391K	–	1364
2023 Q4	$391K	Hold	28,518	–	–	0.01%	1000
2023 Q3	$417K	Hold	28,518	–	–	0.01%	931
2023 Q2	$485K	Hold	28,518	–	–	0.01%	913
2023 Q1	$398K	Hold	28,518	–	–	0.01%	934
2022 Q4	$188K	Buy	+28,518	New	+$171K	﹤0.01%	1098

Other funds holding RCEL

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bridgeway Capital Management's RCEL Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 30,404 shares — an estimated $112K sold.

Bridgeway Capital Management first reported a position in RCEL in Q4 2022 and held it in 9 quarters. The position peaked at $603K in Q3 2025. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Bridgeway Capital Management reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
Bridgeway Capital Management sold 30,404 Avita Medical shares in Q2 2026, an estimated $112K.
Bridgeway Capital Management first reported a position in Avita Medical in Q4 2022 and held it in 9 quarters.
Bridgeway Capital Management's Avita Medical position peaked at $603K in Q3 2025.
74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.